Leadership. Empowerment. Development.

Friday, October 2, 2020

11:00 AM – 11:05 AM	Welcome Remarks and Conference Overview
11:05 AM – 11:45 AM	Professional Vignettes Women oncology leaders share their journeys and perspectives on the past and current state of women in healthcare and how they are amplifying women’s voices in oncology
11:45 AM – 12:15 PM	KEYNOTE Leadership Development
12:15 PM – 1:00 PM	WORKSHOP/PANEL Leadership Strategies
12:45 PM – 1:00 PM	VIRTUAL EXHIBIT HALL
1:00 PM – 1:45 PM	WORKSHOP/PANEL Career Advancement in Oncology Setting Yourself Up for Success Workshop Career Transitions Panel
1:45 PM – 2:15 PM	WORKSHOP/PANEL Health Equity Within Oncology
2:15 PM – 2:30 PM	Award Presentations Woman Oncologists of the Year and Rising Star
2:30 PM – 3:00 PM	Simultaneous Clinical Panel Discussions Hematologic Malignancies Solid Tumors
3:00 PM	Closing Remarks and Adjourn

Friday, October 2, 2020

*All times listed below are Eastern Time (EST)

11:00 AM – 11:05 AM	Welcome Remarks and Conference Overview	Julie Brahmer, MD Johns Hopkins Medicine Nina Shah, MD University of California San Francisco Julie Vose, MD, MBA The University of Nebraska Medical Center
11:05 AM – 11:45 AM	Professional Vignettes Women oncology leaders share their journeys and perspectives on the past and current state of women in healthcare and how they are amplifying women’s voices in oncology	Julie Gralow, MD Seattle Cancer Care Alliance Kristin Hege, MD Bristol Myers Squibb Tatiana Prowell, MD Johns Hopkins Medicine U.S. Food & Drug Administration
11:45 AM – 12:15 PM	KEYNOTE Four Competencies That Define Exceptional Leaders	Gary L. Teal Woodruff Health Sciences Center, Emory University
12:15 PM – 1:00 PM	WORKSHOP/PANEL Leadership Strategies	Gary L. Teal Woodruff Health Sciences Center, Emory University
12:45 PM – 1:00 PM	VIRTUAL EXHIBIT HALL
1:00 PM – 1:45 PM	WORKSHOP/PANEL Career Advancement in Oncology Setting Yourself Up for Success Workshop Career Transitions Panel	Nina Shah, MD – Moderator University of California San Francisco Linda Bosserman, MD City of Hope Nicole Gormley, MD U.S. Food & Drug Administration PK Morrow, MD Amgen Julie Vose, MD, MBA The University of Nebraska Medical Center
1:45 PM – 2:15 PM	WORKSHOP/PANEL Health Equity Within Oncology	Patricia Doykos, PhD Bristol Myers Squibb Narjust Duma, MD University of Wisconsin Nicole Gormley, MD U.S. Food & Drug Administration Dara Richardson-Heron, MD Pfizer
2:15 PM – 2:30 PM	Award Presentations Woman Oncologists of the Year and Rising Star
2:30 PM – 3:00 PM	Simultaneous Clinical Panel Discussions Hematologic Malignancies	Nina Shah, MD – Moderator University of California San Francisco Caitlin Costello, MD UC San Diego Heath Carrie Thompson, MD Mayo Clinic Julie Vose, MD, MBA The University of Nebraska Medical Center Eunice Wang, MD Roswell Park Comprehensive Cancer Center
	Solid Tumors	Julie Brahmer, MD – Moderator Johns Hopkins Medicine Bruna Ferreira Pellini, MD H. Lee Moffitt Cancer Center Julie Gralow, MD Seattle Cancer Care Alliance Jarushka Naidoo, MBBCh Johns Hopkins Medicine Lynn Schuchter, MD Penn Medicine Rachna Shroff, MD The University of Arizona Cancer Center Shannon Westin, MD, MPH The University of Texas MD Anderson Cancer Center
3:00 PM	Closing Remarks and Adjourn	Julie Brahmer, MD Johns Hopkins Medicine Nina Shah, MD University of California San Francisco Julie Vose, MD, MBA The University of Nebraska Medical Center

A Decade of Advancement: Precision Medicine—From Histology to Molecular Subsets	Bruna Pellini, MD H. Lee Moffitt Cancer Center
A Decade of Advancement: Harnessing the Patient Immune System	Lynn Schuchter, MD Penn Medicine
What the Future May Hold: The Microbiome—The Next Target in Cancer Therapy?	Cynthia Sears, MD Johns Hopkins University
Incorporation of Emerging Treatment Options into Clinical Practice Paradigms: Leukemias Lymphomas Multiple Myeloma	Eunice Wang, MD Roswell Park Comprehensive Cancer Center Sonali Smith, MD The University of Chicago Medicine Caitlin Costello, MD UC San Diego Health
Incorporation of Emerging Treatment Options into Clinical Practice Paradigms: Gastrointestinal Cancers Metastatic Breast Cancer	Rachna Shroff, MD, MS University of Arizona Cancer Center Julie Gralow, MD Seattle Cancer Care Alliance
Managing Drug Class Toxicities: PARP Inhibitors in Gynecologic Cancers Checkpoint Inhibitors	Shannon Westin, MD, PhD The University of Texas MD Anderson Cancer Center Jarushka Naidoo, MBBCh Johns Hopkins Medicine
TKIs in Lung Cancer	Lecia Sequist, MD Massachusetts General Hospital
CAR T-cell Therapy	Bianca Santomasso, MD, PhD Memorial Sloan Kettering Cancer Center
Supportive Care for the Female Patient	Anne Katz, MD Weill Cornell Medicine